Similar Prostate Cancer Drugs Show Different Results in Real-World Study

(MedPage Today) — A real-world comparison of two androgen receptor pathway inhibitors (ARPIs) for advanced prostate cancer showed a significant difference in overall survival (OS). Patients with castration-sensitive metastatic prostate cancer…